Kö'ln, Germany

Martin Michels

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • West Haven, CT (US) (2008)
  • Cologne, DE (2010 - 2012)
  • Kölne, DE (2013)
  • Köln, DE (2013 - 2018)

Company Filing History:


Years Active: 2008-2018

Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: The Innovations of Martin Michels - A Pioneer in Pharmaceutical Research

Introduction

Martin Michels is an inventive force hailing from Cologne, Germany. With four patents to his name, he has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for hyper-proliferative disorders and diseases associated with angiogenesis. His relentless pursuit of innovation has positioned him as a notable figure in medical research and development.

Latest Patents

Michels' most recent patents focus on substituted 4-amino-pyrrolotriazine derivatives. These novel compounds and their pharmaceutical compositions are designed to treat hyper-proliferative disorders. These inventions highlight the potential of pyrrozolotriazine compounds, which can be utilized as a sole agent or in conjunction with other active ingredients for treating conditions related to abnormal cell growth and angiogenesis. His groundbreaking work is vital in advancing therapeutic options in modern medicine.

Career Highlights

Throughout his career, Martin Michels has collaborated with prominent organizations such as Bayer Healthcare LLC and Aicuris GmbH & Co. KG. These experiences have not only enhanced his inventive skills but also broadened his understanding of applying scientific research to real-world medical challenges. His work with these reputable companies has allowed him to advance his understanding of pharmaceutical development and patient care.

Collaborations

In his professional journey, Michels has had the privilege of working alongside dedicated professionals like Julie A. Dixon and Barton W. Phillips. Collaborating with such talented individuals has undoubtedly influenced his innovative thinking and contributed to his achievements in the pharmaceutical industry. These partnerships illustrate the importance of teamwork in driving forward medical advancements.

Conclusion

Martin Michels stands out as a significant inventor in the pharmaceutical realm. His patents are a testament to his innovative spirit and commitment to improving healthcare outcomes. Through his work, he continues to inspire future generations of inventors and researchers in their quest to develop groundbreaking solutions for complex medical problems. As the field of pharmaceuticals evolves, the contributions of inventors like Michels will remain integral to its progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…